Eli Lilly and Company

Pharmareferent CMH (m/w/d) Gebiet (310902): Gelsenkirchen, Bottrop, Herten, Gladbeck, Essen-Nord

Germany

Not SpecifiedCompensation
Entry Level & New GradExperience Level
Full TimeJob Type
UnknownVisa
Pharmaceuticals, HealthcareIndustries

Position Overview

  • Company: Eli Lilly and Company
  • Location Type: Onsite
  • Employment Type: Full-time
  • Location: Gelsenkirchen, Bottrop, Herten, Gladbeck, Essen-Nord
  • Job Title: Pharmareferent für CMH (m/w/d) Gebiet

Eli Lilly and Company is a global healthcare leader dedicated to discovering and bringing life-changing medicines to those who need them. With a rich history dating back to 1876, Lilly is committed to uniting caring with discovery and improving the lives of millions worldwide. The Lilly Deutschland GmbH, a subsidiary of Eli Lilly and Company, has a significant presence in Germany with over 1,100 employees based in Bad Homburg vor der Höhe (Hessen). Lilly's key therapeutic and research areas include Alzheimer's disease, pain, cancer, immunology, diabetes, and obesity. This role is based in Bad Homburg bei Frankfurt am Main.

Responsibilities

  • Performing CMH (likely Commercial Medical Affairs) activities.
  • Working independently and as part of cross-functional and self-organized teams to achieve large projects.

Requirements

  • A strong team spirit and appreciation for an equal footing with colleagues at all levels.
  • The ability to contribute ideas and implement them independently.
  • Flexibility in scheduling work hours based on trust.
  • Access to professional development opportunities through the "Corporate Lilly University."

Benefits

  • Work Environment: Informal and equal footing with colleagues.
  • Autonomy: Freedom to contribute ideas and implement them independently.
  • Work-Life Balance: Flexible work hours based on trust.
  • Development: Individual career development support and access to professional training through the "Corporate Lilly University."

Company Information

  • Company Name: Eli Lilly and Company
  • Founded: 1876
  • Headquarters: Indianapolis, Indiana, USA
  • Mission: To unite caring with discovery to make life better for people around the world.
  • Key Therapeutic Areas: Alzheimer’s disease, pain, cancer, immunology, diabetes, and obesity.
  • German Subsidiary: Lilly Deutschland GmbH
  • German Employees: Over 1,100
  • German Headquarters: Bad Homburg vor der Höhe (Hessen)

Skills

Teamwork
Independent working
Flexibility
Idea contribution
Project management
Professional development

Eli Lilly and Company

Develops and delivers prescription medicines globally

About Eli Lilly and Company

Eli Lilly and Company is a global pharmaceutical company that focuses on discovering, developing, and delivering medicines to improve health. The company has a long history of scientific achievements, including the creation of insulin, the first life-saving treatment for diabetes. Lilly's operations involve extensive research and development to create new medications and enhance existing ones, ensuring they are safe and effective. Their products are primarily prescription medicines sold to healthcare providers for various medical conditions, including diabetes, cancer, and pain management. What sets Lilly apart from its competitors is its strong commitment to ethical practices and the protection of its products from counterfeiting. The company's goal is to enhance lives through innovative medical solutions while maintaining high standards of quality and ethics.

Indianapolis, IndianaHeadquarters
1876Year Founded
$1,180.1MTotal Funding
IPOCompany Stage
Biotechnology, HealthcareIndustries
10,001+Employees

Risks

Competition from Novo Nordisk's Ozempic may impact tirzepatide's market share.
Potential construction delays in Indiana could affect GLP-1 drug production timelines.
Regulatory challenges may hinder Kisunla's expansion in new Alzheimer's markets.

Differentiation

Eli Lilly's rich history includes the first life-saving insulin treatment.
Lilly's strategic partnerships enhance its position in neurodegenerative disease treatments.
FDA approval of Zepbound opens new therapeutic markets for sleep disorder treatments.

Upsides

Lilly's $9 billion complex in Indiana boosts GLP-1 drug production capacity.
Kisunla's approval in China expands Lilly's Alzheimer's treatment market in Asia.
Collaboration with EVA Pharma enhances Lilly's reputation as socially responsible.

Land your dream remote job 3x faster with AI